Patient-reported Outcomes Clinical Trial
Official title:
Using Rapid Cycle Randomized Controlled Trials to Increase Completion Rates of the Patient-Reported Health Assessment Questionnaire During Outpatient Visits at NYU Langone Orthopedic Center
| Verified date | October 2022 |
| Source | NYU Langone Health |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The proposed study aims to examine several iterations of instructions/reminders that patients receive for completing the Health Assessment Questionnaire (self-reported health outcomes) for their outpatient visit at NYU Langone Orthopedic Center. The goal is to increase the completion rates of patient-reported health outcomes.
| Status | Completed |
| Enrollment | 27263 |
| Est. completion date | May 31, 2019 |
| Est. primary completion date | May 31, 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A and older |
| Eligibility | Inclusion Criteria: - All patients who are eligible to receive the Health Assessment Questionnaire in preparation for and during their outpatient visit to the NYU Langone Orthopedic Center. Exclusion Criteria: - N/A |
| Country | Name | City | State |
|---|---|---|---|
| United States | New York University School of Medicine | New York | New York |
| Lead Sponsor | Collaborator |
|---|---|
| NYU Langone Health |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Questionnaire Completion Rate (number of times patients complete or partially complete the questionnaire). | Completion rate data is routinely collected by the medical center. | Duration of the study, up to 6 months. |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06012318 -
Dynamic Follow-up of Symptoms Based on Patient-reported Outcomes in Immunotherapy for Esophageal Cancer: a Prospective Multicentre Cohort Study (SPRING)
|
||
| Recruiting |
NCT05596890 -
Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients
|
Phase 2 | |
| Completed |
NCT03341377 -
Perioperative Symptom Study of Lung Cancer (CN-PRO-Lung 1)
|
||
| Recruiting |
NCT05841186 -
Correlation of Timing of Pegfilgrastim Administration and PIBP.
|
N/A |